Erik Atkisson - 02 Mar 2023 Form 4 Insider Report for Rain Oncology Inc.

Role
General Counsel and CCO
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Erik Atkisson
Issuer symbol
N/A
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 16:07:20 UTC
Previous filing
30 Jan 2023
Next filing
11 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 02 Mar 2023 Common Stock 120,000 $9.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 120,000 shares of the Issuer's common stock, one quarter of which will vest on February 21, 2024, with the remaining three quarters vesting in equal monthly installments through February 21, 2027, subject to the Reporting Person's continued service to the Issuer.